37 related articles for article (PubMed ID: 16410701)
1. Aortitis after switching short-acting granulocyte colony-stimulating factors in a lymphoma patient with HLA-B52.
Tane M; Kosako H; Hosoi H; Furuya Y; Hori Y; Yamashita Y; Murata S; Mushino T; Sonoki T
Int J Hematol; 2024 May; 119(5):608-612. PubMed ID: 38521841
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis.
Iida K; Honda Y; Homma Y
BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36750306
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and chemokines as biomarkers of community-acquired bacterial infection.
Holub M; Lawrence DA; Andersen N; Davidová A; Beran O; Marešová V; Chalupa P
Mediators Inflamm; 2013; 2013():190145. PubMed ID: 23690657
[TBL] [Abstract][Full Text] [Related]
4. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
[TBL] [Abstract][Full Text] [Related]
5. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels.
Niitsu N; Khori M; Hayama M; Kajiwara K; Higashihara M; Tamaru J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):697-702. PubMed ID: 15701858
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF)].
Kanbayashi Y; Mukoyama N; Nishida K; Shimizu D; Matsumoto Y; Nomura K; Horiike S; Taniwaki M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):73-7. PubMed ID: 16410701
[TBL] [Abstract][Full Text] [Related]
10. A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents.
Lerro KA; Medoff E; Wu Y; Seropian SE; Snyder E; Krause D; Cooper DL
Bone Marrow Transplant; 2003 Dec; 32(12):1113-7. PubMed ID: 14647264
[TBL] [Abstract][Full Text] [Related]
11. [Management of diffuse large B-cell lymphoma in the rituximab era].
Kinoshita T
Rinsho Ketsueki; 2009 Oct; 50(10):1342-50. PubMed ID: 19915341
[No Abstract] [Full Text] [Related]
12. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
